stars 1 stars 2 stars 3

CAF-DCF is a BENELUX company specialized in the commercialization of plasma derived medicines. We have long term expertise in life-saving products for rare and life-threatening diseases in three therapeutic domains : immunology, intensive care and hemostasis. Our driving values are : Ethical commitment Dedication to BENELUX healthcare services Safety of our products and of patients using them Trust The use of blood plasma drawn from volunteer donors and the preparation of products intended to save patients are the cornerstone of our "human-to-human approach". CAF-DCF is controlled by the French biopharmaceutical group LFB. The company has historically been founded by the Belgian Red Cross and has a 40 years history of ethical product development , production and commercialization in the field of plasma derived medicines.

CAF-DCF Questions

The CAF-DCF annual revenue was $25.1 million in 2026.

Romuald Gaudefroy is the Managing Director of CAF-DCF.

12 people are employed at CAF-DCF.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users